This document discusses guidelines for diagnosing and treating dengue. It notes that dengue is the fastest spreading mosquito-borne viral disease, infecting 50 million people annually. It has increased geographic spread and incidence. The virus has 4 serotypes. Symptoms include fever, rash and bleeding. Management involves fluid replacement and blood transfusion for severe bleeding. Patients are classified into groups A, B or C depending on severity of symptoms and need for hospitalization.
We will discuss briefly common tropical diseases found in INDIA. The presentation is basic for undergraduate students. we are covering dengue, malaria, chikungunya, and rickettsia in this presentation.
Dengue in pregnancy by dr alka mukherjee nagpur m.s. indiaalka mukherjee
Significant outbreaks of dengue fever occur every five or six years. There tend to remain a large number of susceptible people in the population despite previous outbreaks because there are four different strains of the dengue virus and because of new susceptible individuals entering the target population, either through childbirth or immigration.
Dengue infection in pregnancy carries the risk of hemorrhage for both the mother and the newborn. In addition, there is a serious risk of premature birth and foetal death. In case of infection close to term, there is a risk of vertical transmission. Hence the knowledge of its diagnosis and management is of vital importance.
During a recent outbreak we encountered at least seven cases of fever with thrombocytopenia in pregnancy but only two were seropositive for dengue.
Severe Dengue
Successful management of severe dengue requires careful attention to fluid management and proactive treatment of hemorrhage. Admission to an intensive care unit is indicated for patients with dengue shock syndrome.
Patients may need a central intravenous line for volume replacement and an arterial line for accurate blood pressure monitoring and frequent blood tests. Exercise caution when placing intravascular catheters because of the increased bleeding complications of dengue hemorrhagic fever
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
1. DENGUE:
WHO GUIDELINES FOR DIAGNOSIS AND
TREATMENT
Jimmy Mendigo, MD
Infectious Disease Specialist
Chrysanta D. Viernes, MD
Internal Medicine- ITRMC
2. OBJECTIVES
• Discuss the epidemiology and burden of disease of
Dengue
• Review the transmission
• Discuss the new case classification
• Discuss algorithms in the diagnosis and management of
Dengue
3. EPIDEMIOLOGY
• most rapidly spreading mosquito-borne viral
disease in the world
• incidence: 30-fold increase
• increasing geographic expansion to new countries,
and from urban to rural settings
• 50 million dengue infections annually
5. EPIDEMIOLOGY
• 2001-2008: 1, 020,333 cases in Cambodia, Malaysia,
Philippines and Vietnam
• highest reported deaths in 2008
– Cambodia
–Philippines
6. Burden of Disease
• WHO estimates that 2.5 billion people—
over 40% of the world’s population-- are at
risk for dengue infection.
• Approximately 50-100 million infections (1
million confirmed) occur each year resulting
in 500,000 hospitalizations and 20,000
deaths.
7. Dengue Virus Profile
•
•
•
•
Genus Flavivirus
Family Flaviviridae
Single-stranded RNA
4 serotypes (DEN-1 to 4)
• 50 nm diameter with
multiple copies of 3
structural proteins ( membrane
bilayer and single-stranded RNA)
8. Vector Profile
• Aedes mosquitoes
• A. aegypti
• A. albopictus
• A. polynesiensis
• Tropical and
subtropical species
• Urban places
• Immature stages are
found in water-filled
habitats
9. The Host
• Incubation period: 4-10 days
• Primary infection induce
lifelong immunity to the
infecting serotype
• Protection from different
serotype within 2-3
months of primary
infection
• No long-term crossprotective immunity
10. The Host
• Individual risk factors:
• Age, ethnicity, chronic diseases
• Seroepidemiological studies (Cuba and Thailand)
• Secondary heterotypic infection
• Time interval between infections
• Antibody-dependent enhancement of infection
12. Replication and Transmission
Replication in
the salivary
gland
Viral replication
in midgut
Female mosquito
ingests infected
blood
Extrinsic Incubation
• 8--12 days
13. Dengue Fever
• Wide spectrum of clinical presentation, with
unpredictable clinical evolution and outcome
• Three phases
• Febrile phase
• Critical phase
• Recovery phase
• Previously classified into
• undifferentiated fever, dengue fever and DHF
• Grade 1-IV
14. Dengue Fever
Grade 1: fever, non specific constitutional symptoms; (+) TT- only
hgic manifestation
Grade 2: Grade 1 manifestation + spontaneous bleeding
Grade 3: signs of circulatory failure (rapid weak pulse, narrow pulse
pressure, hypotension, cold clammy skin)
Grade 4: profound shock with undetectable pulse and BP
18. Febrile Phase
facial flushing
skin erythema
generalized body ache
myalgia and arthralgia
headache
sorethroat, injected
pharynx, and conjunctival
injection
anorexia, nausea and
vomiting
• Sudden onset of
high-grade fever
• Lasts for 2-7 days
19. Febrile Phase
•
(+) TT increases the
probability of dengue
•
(+) hemorrhagic
earliest abnormality: progressive decrease
manifestations
in total wbc
•
enlarged and tender
liver
20. Critical Phase
• temperature drops to 37.5-38 (days 3-7)
• (+) increase in capillary permeability with
increasing hematocrit levels
• significant plasma leakage lasts for 24-48 hours
• progressive leukopenia followed by rapid
decrease in platelet precedes plasma leakage
21. Critical Phase
• if (-) increase in capillary permeability
improve
• if (+) increase in capillary permeability
pleural effusion and ascites
• degree of increase above the baseline
hematocrit reflects the severity of plasma
leakage
22. Critical Phase
• shock: critical volume of plasma is lost
• temperature may be subnormal
• prolonged shock organ hypoperfusion organ
impairment, metabolic acidosis, and DIC severe
hemorrhage
• severe hepatitis, encephalitis or myocarditis
23. Recovery Phase
• gradual reabsorption of extravascular compartment
fluid (48-72 hours)
• general well-being improves, appetite returns, GI
symptoms abate, hemodynamic status stabilizes and
diuresis ensues
• (+) rash: “isles of white in the sea of red”
26. Approach to the Management
• At primary and secondary levels, health care
facilities are responsible for emergency/
ambulatory triage assessment and treatment
• Triage is the process of rapidly screening patients soon
after their arrival in the hospital or health facility in order
to identify those
– Severe dengue
– With warning signs
– Non-urgent cases
28. Approach to the Management
• Referral centres receiving severely ill dengue patients
must be able to give prompt attention to referred cases.
• Beds should be made available to those patients who meet
the admission criteria
• There should be a designated area to cohort dengue
patients, and a high-dependency unit for closer monitoring
of those with shock.
• Staffed by doctors and nurses
29. Approach to the Management
Criteria for transfer:
•
•
•
•
•
•
early presentation with shock (on days 2 or 3 of illness);
severe plasma leakage and/or shock;
undetectable pulse and blood pressure;
severe bleeding;
fluid overload;
organ impairment (such as hepatic damage,
cardiomyopathy, encephalopathy,
• encephalitis and other unusual complications).
30. Approach to the Management
Disease notification
• In dengue-endemic countries, cases of suspected, probable
and confirmed dengue should be notified
• Public health measures
– suspected cases
•
•
•
•
lives in or has travelled to a dengue-endemic area
fever for three days or more
low ordecreasing white cell counts
thrombocytopaenia ± positive tourniquet test.
31. Approach to the Management
Management Decisions
Groups A
• may be sent
home
• tolerate
adequate
volumes of oral
fluids and pass
urine at least
once every 6
hours
Groups B
• referred for in-
hospital
management
• with warning
signs, coexisting
conditions,
• with certain
social
circumstances
Groups C
• require
emergency
treatment and
urgent referral
• severe
dengue (in
critical phase)
32. Group A Action Plan
•
•
•
Encourage intake of ORS, fruit juice and other fluids
Paracetamol and tepid sponge for fever
Advise to come back if with
no clinical improvement
severe abdominal pain
persistent vomiting
cold and clammy extremities,
lethargy or irritability or restlessness,
bleeding
not passing urine for more than 4–6 hours.
monitor:
temperature pattern, volume of fluid intake and losses, urine output, warning signs, signs of
plasma leakage and bleeding, haematocrit, and white blood cell and platelet counts
33. Group B (with warning signs)
Action Plan
• reference hematocrit before fluid therapy
• isotonic solutions
5–7 ml/kg/hour for 1–2 hours, then reduce to 3–
5 ml/kg/hr for 2–4 hours, and then reduce to 2–3
ml/kg/hr or less according to the clinical
response
reassess:
•
•
haematocrit remains the same or rises only minimally 2–3 ml/kg/hr for
another 2–4 hours
worsening vital signs and rising haematocrit rising 5–10 ml/kg/hour for 1–
2 hours
34. Group B (with warning signs)
Action Plan
Give minimum intravenous fluid volume: maintain
good perfusion and urine output of about 0.5
ml/kg/hr
•
•
Intravenous fluids are usually needed for only 24–48 hours.
Reduce intravenous fluids gradually when the rate of plasma
leakage decreases towards the end of the critical phase.
monitor:
• vital signs and peripheral perfusion (1–4 hourly until the patient is
out of the critical phase)
• urine output (4–6 hourly)
• hematocrit (before and after fluid replacement, then 6–12 hourly)
• blood glucose
• organ functions (renal profile, liver profile, coagulation profile)
35. Group B (without warning signs)
Action Plan
• Encourage oral fluids
• If not tolerated, start intravenous fluid therapy of 0.9%
saline or Ringer’s lactate with or without dextrose at
maintenance rate
•
•
Patients may be able to take oral fluids after a few hours of
intravenous fluid therapy.
Give the minimum volume required to maintain
good perfusion and urine output.
Intravenous fluids are usually needed only for
24–48 hours.
• Close monitoring
36. Group C Action Plan
• admit to a hospital with access to intensive care
facilities and blood transfusion
• plasma losses should be replaced immediately and
rapidly with isotonic crystalloid solution or, in the case
of hypotensive shock, colloid solutions
• blood transfusion: with suspected/severe bleeding
• judicious intravenous fluid
resuscitation: sole intervention required
37. Group C Action Plan
Goals of fluid resuscitation:
• improving central and peripheral circulation
(decreasing tachycardia, improving BP, warm and pink
extremities, and capillary refill time <2 seconds)
•improving end-organ perfusion
– i.e. stable conscious level (more alert or less restless),
urine output ≥ 0.5 ml/kg/hour,
decreasing metabolic acidosis.
38.
39.
40.
41. Treatment of Hemorrhagic Complications
Patients at risk of major bleeding are those who:
• prolonged/refractory shock;
• hypotensive shock and renal or liver failure and/or severe
and persistent metabolic acidosis
•given non-steroidal anti-inflammatory agents
• pre-existing peptic ulcer disease
• anticoagulant therapy
• any form of trauma
42. Treatment of Hemorrhagic Complications
• Blood transfusion is life-saving and should be given as
soon as severe bleeding is suspected or recognized
• Do not wait for the haematocrit to drop too low before
deciding on blood transfusion
• Risk of fluid overload.
43. Treatment of Hemorrhagic Complications
• blood transfusion if with bleeding
• 5-10 ml/kg of PRBC or 10-20 ml/kg FWB
• repeat if with further blood loss or no rise in
hematocrit after transfusion
• little evidence to support transfusion of platelet
concentrate and FFP
• massive bleeding not managed by FWB/PRBC
• may exacerbate fluid overload
44. Management of Complications
•Fluid Overload
Causes:
– excessive and/or too rapid intravenous fluids;
– incorrect use of hypotonic rather than isotonic crystalloid solutions;
– inappropriate use of large volumes of intravenous fluids in patients with
unrecognized severe bleeding;
– inappropriate transfusion of FFP, platelet concentrates and
cryoprecipitates;
– continuation of IVF after plasma leakage has resolved
– co-morbid conditions such as congenital or ischaemic heart disease, chronic
lung and renal diseases
45. Management of Complications
Clinical Features:
– respiratory distress, difficulty
in breathing;
– rapid breathing;
– chest wall in-drawing;
– wheezing (rather than
crepitations);
– large pleural effusions;
– tense ascites;
Other investigations:
• CXR
•ECG
•ABG
46. Management of Complications
•Oxygen therapy
•Stop IVF
•When to discontinue IVF:
– stable blood pressure, pulse and peripheral perfusion;
– haematocrit decreases in the presence of a good pulse volume;
– afebrile for more than 24–48 days (without the use of antipyretics);
– resolving bowel/abdominal symptoms;
– improving urine output
•If necessary, give oral or intravenous furosemide 0.1–0.5 mg/kg/dose
once or twice daily, or continuous infusion of furosemide 0.1
mg/kg/hour.
47. Management of Complications
• If the patient has stable haemodynamic status but is still within the critical
phase, reduce the intravenous fluid accordingly. Avoid diuretics during the
plasma leakage phase
• Patients who remain in shock with low or normal haematocrit levels but show
signs of fluid overload may have occult haemorrhage.
• Careful fresh whole blood transfusion
• repeated small boluses of a colloid solution
The genome is cleaved
by host and viral proteases in three structural proteins (capsid, C, prM, the precursor of
membrane, M, protein and envelope, E) and seven nonstructural proteins (NS).
n recent decades Aedes albopictus has spread from Asia to
Africa, the Americas and Europe, notably aided by the international trade in used tyres
in which eggs are deposited when they contain rainwater.
Antibody dependent enhancement (ADE): ADE is a phenomenon whereby sub-optimal levels of antibodies enhance viral spread rather than clearing the infection. Antibodies specific for a particular dengue serotype are produced during primary infection or acquired by infants from an immune mother. During a second infection with a distinct serotype, these antibodies bind to the new virus but are not sufficient to neutralize the particles. Cell types that naturally engulf immune complexes through “Fcg” receptors take up the bound virus. Increased viral replication and exacerbated inflammatory responses resulting from access to Fcg receptor-bearing cell types are thought to lead to severe disease.
“Original antigenic sin”: Original antigenic sin was a term first coined in the 1960s to describe a phenomenon observed for influenza virus whereby the human immune system works against itself when trying to mount a response. When the body has been infected before, it can undergo a memory immune response upon seeing the agent again. In the case of original antigenic sin, the body mistakenly mounts a memory response to a similar, previously seen pathogen rather than to the current infection –- for example against the primary, rather than secondary, dengue serotype. Because the memory response is dominant, the body cannot properly fight the new infection. Original antigenic sin can impact both humoral and cellular immune responses.
the classifi cation into levels of severity has a high potential for being of practical use in
the clinicians’ decision as to where and how intensively the patient should be observed
and treated (i.e. triage, which is particularly useful in outbreaks), in more consistent
reporting in the national and international surveillance system, and as an end-point
measure in dengue vaccine and drug trials.
Clinical features are indistinguishable bet wevere and non-severe dengue cases therefore monitoring for warning signs and other clinical parameters is crucial to recognizing progression to the critical phase
Bleeding may occur in this phase but they are not common
CBC picture should alert the physician to a high probability of dengue